Bioloom Islands
×
CINEC Campus
Research partnership
Skin care that reads the skin first
Bioloom Islands (Pvt) Ltd engineers the platform; CINEC Campus supervises the research behind it. One skin profile decides the formula, rather than a shelf.
This page sets out the programme in development and the questions it is built around: the read layer, the engineered-biology track and the genetic layer, each with its own scope.
The loop
Four steps, three layers, and the last one feeds the first.
The patch and the scan are only the read layer. Underneath them sit the engineered-biology track and the genetic layer, and both now have a scope: what they are allowed to decide, and what they are not.
Every product that goes out becomes the next reading that comes back in.
Sense
A colorimetric patch reads sweat pH and UV dose for a week; the phone scan reads it against a printed reference card. This is also where a cell-free sensing circuit would sit, once one clears simulation.
Understand
Patch readings, the microbiome swab and — where it earns its place — a genetic input combine into one skin profile that updates daily.
Design
The constraint model resolves actives and concentrations by priority, inside pH windows and permitted limits. Biosynthesis is scoped as a supply question, not a shortcut.
Deliver
Your batch is compounded locally, labelled with its own record, and shipped with the next patch — whose readings re-open the loop.
Patch, scan, ambient node
Chemistry and optics. No wet lab, no charging, no clinic visit — the bar any biological sensor has to clear later.
Engineered biology
Cell-free sensing circuits and biosynthesis routes, designed and simulated computationally. Nothing engineered and viable reaches a client.
Genetic layer
Bounded to cosmetic-relevant variants, weighting a formulation only — never health, disease or ancestry. Which markers qualify is the question R5 answers.
layers in the loop — read, biology, genetic
open research tracks for CINEC student projects
seasons each formulation has to hold up across
The ecosystem · synthetic biology scope
The instruments read. The biology is what we are expanding into.
Synthetic biology and genetic-level research directions, mapped against what already exists. Hover a node to read the direction and how far it has got. Each one is an active line of research, and the page marks the stage it has reached.
{{ ecoTitle }}
{{ ecoBody }}
The partnership
Industry engineering, campus research.
Bioloom Islands (Pvt) Ltd develops the platform. CINEC Campus provides the research grounding — and the students who do the work.
Industry partner
Bioloom Islands (Pvt) Ltd
Owns the platform, the device roadmap and the formulation engine. Carries product registration, data governance and everything a client actually receives.
Research partner
CINEC Campus
Provides supervision, method review and independent validation. Student research projects run inside the platform's open questions, not alongside them.
Open research tracks — student projects
Marker panel validation
Characterising each sensing pad against known concentrations, and establishing the measurement error that decides when a reading counts as a real change.
Tropical skin baselines
Building reference ranges for Fitzpatrick IV–VI skin across monsoon and inter-monsoon conditions — the data the global literature does not cover.
In silico circuit design
Designing and simulating cell-free sensing circuits computationally, so candidates are narrowed before anything is committed to a printing run.
Formulation constraint modelling
Encoding compatibility rules — pH windows, incompatible actives, permitted concentrations — so competing adjustments resolve by priority rather than by averaging.
Genetic layer
The track researches which genetic markers add information the patch and the scan do not already carry, and how strongly each should weight a formulation.
Work runs marker by marker: published evidence reviewed, effect sizes checked against readings taken from this cohort, and the result documented. A genetic input weights a cosmetic formulation only — never a statement about health, disease or ancestry.
Markers under research — the current reading list
FLG
Filaggrin — the most studied barrier-function gene. Also carries clinical disease associations, which is precisely why a cosmetic platform has to decide what it would refuse to report.
AQP3
Aquaporin-3, a water and glycerol channel in the epidermis. Directly adjacent to the hydration read the patch already estimates — so the test is whether it adds anything the patch does not.
MC1R
Pigmentation and UV response. Well characterised in lighter-skinned cohorts; whether its reported effects hold for Fitzpatrick IV–VI is exactly the gap R2 exists to measure.
MMP1
Matrix metalloproteinase-1, collagen turnover under UV exposure. Pairs with the cumulative UV dose the patch records, which is the only way a variant becomes actionable.
SOD2 · GPX1 · CAT
Oxidative-stress handling. Frequently cited in cosmetic genomics and just as frequently on thin evidence — a candidate for exclusion as much as inclusion.
TYR · SLC45A2
Melanin synthesis and transport, against the melanin index the scan computes. Any marker here is read as formulation context, never as ancestry.
These are the starting points for the review. Published effect sizes in cosmetic genomics are small and often unreplicated, most of the work was done outside this cohort, and any marker with a clinical disease association is a candidate for exclusion on that basis alone.
Student work is supervised, credited and published where the results support it. Anything that reaches a client passes through validation first — a research finding is not a product claim.
×
The instruments are in development and not offered for sale. Cosmetic products will be registered with the NMRA before any sale. Genetic and biosensor data is stored separately, encrypted, and deleted on request under the Personal Data Protection Act. Bioloom Islands (Pvt) Ltd × CINEC Campus, 2026.